Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Oncofertility w praktyce klin.
  • Obniżka

Principles and Practice of Infectious Diseases e-dition

Text with Continually Updated Online Reference, 2-Volume Set

9780443066733
2 061,36 zł
1 855,22 zł Zniżka 206,14 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 855,22 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
This e-dition includes the 2-volume set PLUS access to www.ppidonline.com!

Widely acknowledged as the definitive reference source of its kind, Principles and Practice of Infectious Diseases is back - in a new 6th Edition! Authored by a whos who of experts from around the world, it encompasses all that is currently known about the epidemiology, aetiology, pathology, microbiology, immunology, and treatment of infectious agents. Completely revised and updated - and with a bold, new 4-colour format - it is a complete, essential compendium of knowledge on this vast and complex subject.

The accompanying website at www.ppidonline.com features the full contents of the book in a fully searchable format, plus weekly updates to content, ensuring this outstanding reference keeps pace with the changing world of infectious diseases.

The 2-volume set also includes a bound-in CD-ROM with all of the images from the book available for PowerPoint download.
Szczegóły produktu
Churchill Livingstone
35699
9780443066733
9780443066733

Opis

Rok wydania
2004
Numer wydania
6
Oprawa
twarda
Liczba stron
4000
Wymiary (mm)
216 x 276
Waga (g)
9276
  • VOLUME 1

    Part I. Basic Principles in the Diagnosis and Management of Infectious Diseases
    SECTION A. MICROBIAL VIRULENCE FACTORS
    1. A Molecular Perspective of Microbial Pathogenicity
    2. Microbial Adherence
    3. Toxins
    SECTION B. HOST DEFENSE MECHANISMS
    4. Innate (General or Nonspecific) Host Defense Mechanisms
    5. Human Genetics and Infection
    6. Antibodies
    7. Complement
    8. Granulocytic Phagocytes
    9. Cell-Mediated Defense against Infection
    10. Nutrition, Immunity, and Infection
    11. Evaluation of the Patient with Suspected Immunodeficiency
    SECTION C. EPIDEMIOLOGY OF INFECTIOUS DISEASES
    12. Epidemiologic Principles
    13. Emerging and Re-emerging Infectious Disease Threats
    14. Hospital Preparedness for Emerging and Highly Contagious Infections Diseases: Getting Ready for SARS or Whatever Comes Next
    SECTION D.
    15. The Clinician and the Microbiology Laboratory
    SECTION E. ANTI-INFECTIVE THERAPY
    16. Principles of Anti-infective Therapy
    17. Molecular Mechanisms of Antibiotic Resistance in Bacteria
    18. Pharmacokinetics and Pharmacodynamics of Anti-infective Agents
    19. Penicillins
    20. Cephalosporins
    21. Other b-Lactam Antibiotics
    22. b-Lactam Allergy
    23. Fusidic Acid
    24. Aminoglycosides
    25. Tetracyclines and Chloramphenicol
    26. Rifamycins
    27. Metronidazole
    28. Macrolides, Clindamycin, and Ketolides
    29. Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), and Lipopeptides (Daptomycin)
    30. Polymyxins (Polymixin B and Colistin)
    31. Oxazolidinones
    32. Sulfonamides and Trimethoprim
    33. Quinolones
    34. Urinary Tract Agents: Nitrofurantoin and Methenamine
    35. Topical Antibacterials
    36. Antimycobacterial Agents
    37. Systemic Antifungal Agents
    38. Antiviral Drugs (Other Than Antiretrovirals)
    39. Immunomodulators
    40. Hyperbaric Oxygen
    41. Agents Active against Parasites and Pneumocystis
    42. Complementary and Alternative Medicines for Infectious Diseases
    43. Antimicrobial Management and Cost Containment
    44. Interpretating the Results of Clinical Trials on Antimicrobial Agents
    45. Outpatient Intravenous Antibiotic Therapy
    46. Tables of Antimicrobial Agent Pharmacology
    PART II. Major Clinical Syndromes
    SECTION A. FEVER
    47. Temperature Regulation and the Pathogenesis of Fever
    48. Fever of Unknown Origin
    49. The Acutely Ill Patient with Fever and Rash
    SECTION B. UPPER RESPIRATORY TRACT INFECTIONS
    50. The Common Cold
    51. Pharyngitis
    52. Acute Laryngitis
    53. Acute Laryngotracheobronchitis (Croup)
    54. Otitis Externa, Otitis Media, and Mastoiditis
    55. Sinusitis
    56. Epiglottitis
    57. Infections of the Oral Cavity, Neck, and Head
    SECTION C. PLEUROPULMONARY AND BRONCHIAL INFECTIONS
    58. Acute Bronchitis
    59. Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, and Acute Exacerbations
    60. Bronchiolitis
    61. Acute Pneumonia
    62. Pleural Effusion and Empyema
    63. Lung Abscess
    64. Chronic Pneumonia
    65. Cystic Fibrosis
    SECTION D. URINARY TRACT INFECTION
    66. Urinary Tract Infections
    SECTION E. SEPSIS
    67. Sepsis, Severe Sepsis, and Septic Shock
    SECTION F. INTERABDOMINAL INFECTION
    68. Peritonitis and Intraperitoneal Abscesses
    69. Infections of the Liver and Biliary System
    70. Pancreatic Infections
    71. Splenic Abscess
    72. Appendicitis
    73. Diverticulitis and Typhlitis
    SECTION G. CARDIOVASCULAR INFECTIONS
    74. Endocarditis and Intravascular Infections
    75. Infections of Prosthetic Valves and Other Cardiovascular Devices
    76. Prophylaxis of Infective Endocarditis
    77. Myocarditis and Pericarditis
    78. Mediastinitis
    SECTION H. CENTRAL NERVOUS SYSTEM INFECTIONS
    79. Approach to the Patient with Central Nervous System Infection
    80. Acute Meningitis
    81. Cerebrospinal Fluid Shunt Infections
    82. Chronic Meningitis
    83. Encephalitis, Myelitis, and Neuritis
    84. Brain Abscess
    85. Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis
    SECTION I. SKIN AND SOFT TISSUE INFECTIONS
    86. Cellulitis and Subcutaneous Tissue Infections
    87. Myositis
    88. Lymphadenitis and Lymphangitis
    SECTION J. GASTROINTESTINAL INFECTIONS AND FOOD POISONING
    89. Principles and Syndromes of Enteric Infection
    90. Esophagitis
    91. Nausea, Vomiting, and Noninflammatory Diarrhea
    92. Antibiotic-Associated Colitis
    93. Inflammatory Enteritides
    94. Enteric Fever and Other Causes of Abdominal Symptoms with Fever
    95. Foodborne Disease
    96. Tropical Sprue/Enteropathy
    97. Whipples Disease
    SECTION K. BONE AND JOINT INFECTIONS
    98. Infectious Arthritis of Native Joints
    99. Osteomyelitis
    100. Infections with Prostheses in Bones and Joints
    SECTION L. DISEASES OF THE REPRODUCTIVE ORGANS AND SEXUALLY TRANSMITTED DISEASES
    101. Genital Skin and Mucous Membrane Lesions
    102. Urethritis
    103. Vulvovaginitis and Cervicitis
    104. Infections of the Female Pelvis
    105. Prostatitis, Epididymitis, and Orchitis
    SECTION M. EYE INFECTIONS
    105. Microbial Conjunctivitis
    107. Microbial Keratitis
    108. Endophthalmitis
    109. Infectious Causes of Uveitis
    110. Periocular Infections
    SECTION N. HEPATITIS
    111. Acute Viral Hepatitis
    112. Chronic Viral Hepatitis
    SECTION O. ACQUIRED IMMUNODEFICIENCY SYNDROME
    113. Global Perspectives on Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
    114. Epidemiology and Prevention of Acquired Immunodeficiency Syndrome and Human Immunodeficiency Virus Infection
    115. Diagnosis of Human Immunodeficiency Virus Infection
    116. The Immunology of Human Immunodeficiency Virus Infection
    117. General Clinical Manifestations of Human Immunodeficiency Virus Infection (Including the Acute Retroviral Syndrome and Oral, Cutaneous, Renal, Ocular, and Cardiac Diseases)
    118. Pulmonary Manifestations of Human Immunodeficiency Virus Infection
    119. Gastrointestinal and Hepatobiliary Manifestations of Human Immunodeficiency Virus Infection
    120. Neurologic Diseases Caused by Human Immunodeficiency Virus-1 and Opportunistic Infections
    121. Malignancies in Human Immunodeficiency Virus Infection
    122. Human Immunodeficiency Virus Infection in Women
    123. Pediatric Human Immunodeficiency Virus Infection
    124. Antiretroviral Therapy for Human Immunodeficiency Virus Infection
    125. Management of Opportunistic Infections Associated with Human Immunodeficiency Virus Infection
    126. Vaccines for Human Immunodeficiency Virus-1 Infection
    SECTION P. MISCELLANEOUS SYNDROMES
    127. Chronic Fatigue Syndrome
    Index, i

    VOLUME 2

    PART III. Infectious Diseases and Their Etiologic Agents
    SECTION A. VIRAL DISEASES
    128. Introduction to Viruses and Viral Diseases
    129. Orthopoxviruses: Vaccinia (Smallpox Vaccine), Variola (Smallpox), Monkeypox, and Cowpox
    130. Other Poxviruses That Infect Humans: Parapoxviruses, Molluscum Contagiosum, and Yatapox
    131. Introduction to Herpesviridae
    132. Herpes Simplex Virus
    133. Varicella-Zoster Virus
    134. Cytomegalovirus
    135. Epstein-Barr Virus (Infectious Mononucleosis)
    136. Human Herpesvirus Types 6 and 7
    137. Kaposis Sarcoma−Associated Herpesvirus (Human Herpesvirus Type 8)
    138. Herpes B Virus
    139. Adenovirus
    140. Papillomaviruses
    141. JC, BK, and Other Polyomaviruses; Progressive Multifocal Leukoencephalopathy
    142. Hepatitis B Virus and Hepatitis Delta Virus
    143. Parvovirus B19
    144. Orthoreoviruses and Orbiviruses
    145. Coltiviruses and Seadornaviruses (Colorado Tick Fever)
    146. Rotaviruses
    147. Alphaviruses
    148. Rubella Virus (German Measles)
    149. Flaviviruses (Yellow Fever, Dengue, Dengue Hemorrhagic Fever, Japanese Encephalitis, West Nile Encephalitis, St. Louis Encephalitis, Tick-Borne Encephalitis)
    150. Hepatitis C
    151. Hepatitis G Virus and TT Virus
    152. Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus
    153. Parainfluenza Viruses
    154. Mumps Virus
    155. Respiratory Syncytial Virus
    156. Human Metapneumovirus
    157. Measles Virus (Rubeola)
    158. Zoonotic Paramyxoviruses: Hendra, Nipah, and Menangle Viruses
    159. Vesicular Stomatitis and Related Viruses
    160. Rabdoviruses
    161. Marburg and Ebola Virus Hemorrhagic Fevers
    162. Influenza Virus
    163. California Encephalitis, Hantavirus Pulmonary Syndrome, and Bunyavirid Hemorrhagic Fevers
    164. Lymphocytic Choriomeningitis Virus, Lassa Virus, and the South American Hemorrhagic Fevers
    165. Human T-Cell Lymphotropic Virus Types I and II
    166. Human Immunodeficiency Viruses
    167. Introduction to the Enteroviruses
    168. Poliovirus
    169. Coxsackieviruses, Echoviruses, and Newer Enteroviruses
    170. Hepatitis A Virus
    171. Rhinovirus
    172. Noroviruses and Other Caliciviruses
    173. Astroviruses and Picobirnaviruses
    174. Hepatitis E Virus
    SECTION B. PRION DISEASES
    175. Prions and Prion Diseases of the Central Nervous System (Transmissible Neurodegenerative Diseases)
    SECTION C. CHLAMYDIAL DISEASES
    176. Introduction to Chlamydial Diseases
    177. Chlamydia trachomatis (Trachoma, Perinatal Infections, Lymphogranuloma Venereum, and Other Genital Infections)
    178. Chlamydophila (Chlamydia) psittaci (Psittacosis)
    179. Chlamydophila (Chlamydia) pneumoniae
    SECTION D. MYCOPLASMA DISEASES
    180. Introduction to Mycoplasma Diseases
    181. Mycoplasma pneumoniae and Atypical Pneumonia
    182. Genital Mycoplasmas: Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma urealyticum
    SECTION E. RICKETTSIOSES AND EHRLICHIOSES
    183. Introduction to Rickettsioses and Ehrlichioses
    184. Rickettsia rickettsii and Other Spotted Fever Group Rickettsiae (Rocky Mountain Spotted Fever and Other Spotted Fevers)
    185. Rickettsia akari (Rickettsialpox)
    186. Coxiella burnetii (Q Fever)
    187. Rickettsia prowazekii (Epidemic or Louse-Borne Typhus)
    188. Rickettsia typhi (Murine Typhus)
    189. Scrub Typhus
    190. Ehrlichia chaffeensis (Human Monocytotropic Ehrlichiosis), Anaplasma phagocytophila (Human Granulocytotropic Anaplasmosis), and Other Ehrlichieae
    SECTION F. BACTERIAL DISEASES
    191. Introduction to Bacteria and Bacterial Diseases
    192. Staphylococcus aureus (Including Staphylococcal Toxic Shock)
    193. Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci
    194. Classification of Streptococci
    195. Streptococcus pyogenes
    196. Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and Glomerulonephritis
    197. Streptococcus pneumoniae
    198. Enterococcus Species, Streptococcus bovis, and Leuconostoc Species
    199. Streptococcus agalactiae (Group B Streptococcus)
    200. Viridans Streptococci, Groups C and G Streptococci, and Gemella morbillorum
    201. Streptococcus anginosus Group (or milleri Group or intermedius Group)
    202. Corynebacterium diphtheriae
    203. Other Coryneform Bacteria and Rhodococcus
    204. Listeria monocytogenes
    205. Bacillus anthracis (Anthrax)
    206. Bacillus Species and Related Genera Other Than Bacillus anthracis
    207. Erysipelothrix rhusiopathiae
    208. Neisseria meningitidis
    209. Neisseria gonorrhoeae
    210. Moraxella (Branhamella) catarrhalis and Other Gram-Negative Cocci
    211. Vibrio cholerae
    212. Other Pathogenic Vibrios
    213. Campylobacter jejuni and Related Species
    214. Helicobacter pylori and Other Gastric Helicobacter Species
    215. Enterobacteriaceae
    216. Pseudomonas aeruginosa
    217. Stenotrophomonas maltophilia and Burkholderia cepacia
    218. Burkholderia pseudomallei and Burkholderia mallei: Melioidosis and Glanders
    219. Acinetobacter Species
    220. Salmonella Species, Including Salmonella typhi
    221. Shigella Species (Bacillary Dysentery)
    222. Haemophilus Infections
    223. Brucella Species
    224. Francisella tularensis (Tularemia)
    225. Pasteurella Species
    226. Yersinia Infections, Including Plague
    227. Bordetella Species
    228. Streptobacillus moniliformis (Rat-Bite Fever)
    229. Legionnaires Disease and Pontiac Fever
    230. Other Legionella Species
    231. Capnocytophaga
    232. Infections Due to Bartonella Species, Including Cat-Scratch Disease
    233. Calymmatobacterium granulomatis (Donovanosis, Granuloma Inguinale)
    234. Other Gram-Negative Bacilli
    235. Treponema pallidum (Syphilis)
    236. Endemic Treponematoses
    237. Leptospirosis
    238. Borrelia Species (Relapsing Fever)
    239. Borrelia burgdorferi (Lyme Disease, Lyme Borreliosis)
    240. Spirillum minus (Rat-Bite Fever)
    241. Anaerobic Infections: General Concepts
    242. Clostridium tetani (Tetanus)
    243. Clostridium botulinum (Botulism)
    244. Gas Gangrene and Other Clostridium-Associated Diseases
    245. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli)
    246. Anaerobic Cocci
    247. Anaerobic Gram-Positive Nonsporulating Bacilli
    248. Mycobacterium tuberculosis
    249. Mycobacterium leprae (Leprosy, Hansens Disease)
    250. Mycobacterium avium Complex
    251. Infections Due to Nontuberculous Mycobacteria
    252. Nocardia Species
    253. Agents of Actinomycosis
    SECTION G. MYCOSES
    254. Introduction to Mycoses
    255. Candida Species
    256. Aspergillus Species
    257. Agents of Mucormycosis and Related Species
    258. Sporothrix schenckii
    259. Agents of Chromoblastomycosis
    260. Agents of Mycetoma
    261. Cryptococcus neoformans
    262. Histoplasma capsulatum
    263. Blastomyces dermatitidis
    264. Coccidioides Species
    265. Dermatophytosis and Other Superficial Mycoses
    266. Paracoccidioides brasiliensis
    267. Uncommon Fungi
    268. Pneumocystis Species
    SECTION H. PROTOZOAL DISEASES
    269. Introduction to Protozoal Diseases
    270. Entamoeba histolytica (Amebiasis)
    271. Free-Living Amebas
    272. Plasmodium Species (Malaria)
    273. Leishmania Species: Visceral (Kala-Azar), Cutaneous, and Mucocutaneous Leishmaniasis
    274. Trypanosoma Species (American Trypanosomiasis, Chagas Disease): Biology of Trypanosomes
    275. Agents of African Trypanosomiasis (Sleeping Sickness)
    276. Toxoplasma gondii
    277. Giardia lamblia
    278. Trichomonas vaginalis
    279. Babesia Species
    280. Cryptosporidiosis (Cryptosporidium hominis, Cryptosporidium parvum, and Other Species)
    281. Cyclospora cayetanensis, Isospora belli, Sarcocystis Species, Balantidium coli, and Blastocystis hominis
    282. Microsporidiosis
    SECTION I. DISEASES DUE TO TOXIC ALGAE
    283. Human Illness Associated with Harmful Algal Blooms
    SECTION J. DISEASES DUE TO HELMINTHS
    284. Introduction to Helminth Infections
    285. Intestinal Nematodes (Roundworms)
    286. Tissue Nematodes. Including Trichinosis, Dracunculiasis, and the Filariases
    287. Trematodes (Schistosomes and Other Flukes)
    288. Cestodes (Tapeworms)
    289. Visceral Larva Migrans and Other Unusual Helminth Infections
    SECTION K. ECTOPARASITIC DISEASES
    290. Introduction to Ectoparasitic Diseases
    291. Lice (Pediculosis)
    292. Scabies
    293. Myiasis and Tungiasis
    294. Mites (Including Chiggers)
    295. Ticks (Including Tick Paralysis)
    SECTION L: DISEASES OF UNKNOWN ETIOLOGY
    296. Kawasaki Syndrome
    PART IV. Special Problems
    304. Human Immunodeficiency Virus in Health Care Settings
    305. Nosocomial Herpesvirus Infections
    SECTION B. INFECTIONS IN SPECIAL HOSTS
    306. Infections in the Immunocompromised Host: General Principles
    307. Infections in Patients with Hematologic Malignancies
    308. Prophylaxis and Empirical Therapy for Infection in Cancer Patients
    309. Infections in Injection Drug Users
    310. Risk Factors and Approaches to Infections in Transplant Recipients
    311. Infections in Recipients of Hematopoietic Stem Cell Transplantation
    312. Infections in Solid Organ Transplant Recipients
    313. Infections in Patients with Spinal Cord Injury
    314. Infections in the Elderly
    315. Infections in Asplenic Patients
    SECTION C. SURGICAL- AND TRAUMA-RELATED INFECTIONS
    316. Postoperative Infections and Antimicrobial Prophylaxis
    317. Burns
    318. Bites
    SECTION D. IMMUNIZATION
    319. Immunization
    SECTION E. BIODEFENSE
    320. Bioterrorism: An Overview
    321. Plague as an Agent of Bioterrorism
    322. Francisella tularensis (Tularemia) as an Agent of Bioterrorism
    323. Smallpox and Bioterrorism
    324. Anthrax
    325. Botulinum Toxin as a Biological Weapon
    326. Bioterrorism: Viral Hemorrhagic Fevers
    SECTION F. ZOONOSES
    327. Zoonoses
    SECTION G. PROTECTION OF TRAVELERS
    328. Protection of Travelers
    329. Infections in Returning Travelers
    SECTION H. THE INTERNET
    330. The Infectious Diseases Physician and Digital Resources
    Index
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów